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Objectives.Thecurrentstudywasconductedtodeterminetherelationshipbetweenthepresencesofsigniﬁcantmultidrugresistance
in Pseudomonas aeruginosa (P. aeruginosa) having intact mexR genes (nalC) to diﬀerent antibiotics. Methods.I no r d e rt oi d e n t i f y
nalC,ﬁftystrainsofP. aeruginosa wereobtained.Allisolateswerefoundinurinarytractinfections.Theywereevaluatedagainstdif-
ferentantibiotics.ThenalCmutantwasidentiﬁedbyPCR.Results.The50clinicalisolatesofP. aeruginosa originatedfromtwohos-
pitals in Iran, in which 32 isolates were found in Milad hospital, and 18 isolates were collected in the Ilam Hospital. The results in
Milad hospital of nalC revealed that all P. aeruginosa resistant to oxacillin showed the presence of nalC. In Ilam hospital only three
(16.6%)isolateswereresistanttooxacilinandaztreonam,andamongthesethreeisolatesonlyoneisolaterevealedresistancetoceft-
azidime and amikacin. The resistant isolates showed the presence of both OXA-10 and nalC. Conclusion. Our results showed that
thepresenceofnalCwasobservedamongP. aeruginosa resistancetooxacilin.Thus,theﬁndingsuggestedrelationshipbetweenoxa-
cilin resistance and presence of nalC and consequently overproduction of the MexABOprM eﬄux system.
1.Introduction
P. aeruginosa is an opportunistic human pathogen character-
ized by an innate resistance to multiple antimicrobials [1]. P.
aeruginosa is responsible for 10–15% of the nosocomial in-
fections worldwide [2]. Often these infections are hard to
treat due to the natural resistance of the species as well as to
its remarkable ability of acquiring further mechanisms of re-
sistance to multiple groups of antimicrobial agents.
Oxacillinases (OXA-type enzymes) belong to molecular
class D and functional group 2 [3]. Classical OXA enzymes
(OXA-1, OXA-2, and OXA-10) determine resistance to car-
boxypenicillins and ureidopenicillins but not to ceftazidime
[4]. Resistance to ticarcillin and piperacillin resulting from
production of OXA-2 enzymes is lower than the resistance
that develops when OXA-10 and OXA-1 oxacillinases are
produced[4].Generally,P. aeruginosa clinicalisolatesareless
susceptible than Enterobacteriaceae to most classes of anti-
microbials. For a long time the main reason for this natural
resistance was considered to be the low outer membrane per-
meability due to the presence of proteins with high mole-
cular mass about 50kDa [5].
Eﬄux contributes to the development of multiple resis-
tances to all strategic antipseudomonal antibiotics and is
mediated by four genetically diﬀerent three component ef-
ﬂux systems that belong to the resistance-nodulation-divi-
sion (RND) family: MexA-MexB-OprM, MexC-MexD-OprJ,
MexE-MexF-OprN, and MexX-MexY-OprM. The ﬁrst com-
ponent is a protein located in the cytoplasmic membrane
(MexB, MexD, MexF, and MexY) that operates as an energy-
dependent pump with wide substrate speciﬁcity. The second
componentisagatedoutermembraneprotein(OprM,OprJ,
OprN, and OprM). The third protein (MexA, MexC, MexE,
and MexX) is located in the periplasmic space and links the
other two [6].
There are also other mutants called nalC that have intact
mexR genes [7]. nalC mutants originate from the wild-type
P. aeruginosa PAO1 and are characterized by a mutation in2 International Journal of Microbiology
the PA3721 gene [8] .T h ep r o t e i ne n c o d e db yt h i sg e n ei sa
repressor of a two-gene operon; its function is unclear, and
its overexpression in nalC mutants leads to overproduction
of the MexAB-OprM eﬄux system.
The current study was conducted to determine the rela-
tionship between the presence of the nalC mutation in
P. aeruginosa and its resistance to antibiotics.
2.MaterialandMethods
2.1. Bacterial Strains. In order to identify nalC, ﬁfty strains
of Pseudomonas aeruginosa obtained during the period of
March 2010 to August 2010 in the Milad and Ilam hospitals,
from which 32 isolates were from the Milad hospital, and 18
isolates were from the Ilam hospital. All isolates were isolated
from urinary tract infections.
P. aeruginosa which was resistant to cefotaxime, ceftazi-
dime, amikacin, oxacillin, aztreonam, and ticarcillin was
ESBLs positive, and the presence of OXA-2 and OXA-10 was
assayed by the PCR for detection of ESBLs genes.
2.2. PCR. PCR was performed for detection of OXA-10 and
OXA-2 genes. The primers used were as follows:
OXA-2 gene; Forward 5-GCC AAA GGC ACG ATA
GTT GT-3;
Reverse 5-GCG TCC GAG TTG ACT GCC GG-3;
OXA-10 gene; Forward: 5-GT CTT TCG AGT ACG
GCA TTA-3;
Reverse 5-ATT TTC TTA GCG GCA ACT TAC-3.
2.3. PCR for Detection of NalC. NalC was identiﬁed by using
of Forward: 5-TCA ACC CTA ACG AGA AAC GCT-3 and
Reverse 5-TCC ACC TCA CCG AAC TGC-3.
3. Results
The 50 clinical isolates of P. aeruginosa originated from two
hospitals in Iran, which from 32 isolates were collected in
the Milad hospital, and 18 isolates collected in the Ilam Hos-
pital. After the identiﬁcation of isolates as P. aeruginosa, they
were evaluated for susceptibility to diﬀerent antibiotics. The
ﬁnding in Milad hospital revealed that 87.1% (n = 25) of
the isolates that expressed resistance to oxacilin and resis-
tance to cefotaxime, ceftazidime, amikacin, aztreonam, and
Ticarcillin were 62.5% (n = 20), 50% (n = 16), 56.25% (n =
18), and 68.75% (n = 22), respectively. The ﬁndings show-
ed that all oxacilin resistant strains harbored OXA-10, while
only 2 isolates showed OXA-2 genes. Therefore, two isolates
harbored both OXA-10 and OXA-2. The results of deter-
mining nalC revealed that all P.aeruginosa resistant to oxa-
cilin showed the presence of nalC. Therefore, 87.1% of
P. aeruginosa harbored nalC, in addition, 7 P. aeruginosa
which were negative for nalC also were susceptible to the
othersantibiotics.Therewasasigniﬁcantdiﬀerenceobserved
between the presence of nalC and oxacilin resistant strains.
In Ilam hospital only three (16.6%) isolates were resistant
to oxacilin and aztreonam, and among these three isolates
only one isolate was resistant to ceftazidime and amikacin.
The resistant isolates showed the presence of both OXA-10
and nalC. The ﬁndings showed that no nalC was observed in
sensitive isolates in both hospitals. A signiﬁcant diﬀerence
was observed among resistant strains to oxacilin and the
presence of nalC, while no signiﬁcant diﬀerence occurred
among resistance strains to the other antibiotics and nalC.
4. Discussion
P. aeruginosa presents a therapeutic challenge for treatment
of both community-acquired and nosocomial infections.
Unfortunately, selection of the most appropriate antibiotic is
complicated by the ability of P. aeruginosa to develop resist-
ance to multiple classes of antibacterial agents, even during
the course of treating an infection [9]. Epidemiological out-
come studies have shown that infections caused by drug-
resistant P. aeruginosa are associated with signiﬁcant in-
creases in morbidity, mortality, the need for surgical inter-
vention, the length of hospital stay and chronic care, and the
overall cost of treating the infection [10].
Resistance to ticarcillin and piperacillin resulting from
the production of OXA-2 enzymes is lower than the resis-
tance that develops when OXA-10 and OXA-1 oxacillinases
are produced [4]. The results of this study showed that OXA-
2 enzyme was found in two isolates which demonstrated
resistance to ticarcillin.
The results showed a signiﬁcant diﬀerence between nalC
and oxacilin resistant strains.
MexA-MexB-OprM overproduction often occurs in clin-
ical isolates of P. aeruginosa, and usually it is a result of in-
creased transcription of the mexA-mexB-oprM operon due
to mutations in the chromosomal gene encoding the MexR
repressor protein, that is, mutations at the mexR locus [11].
The protein encoded by this gene is a repressor of a two-gene
operon;itsfunctionisunclear,anditsoverexpressioninnalC
mutants leads to overproduction of the MexAB-OprM eﬄux
system.
In conclusion, Nalc exists as an important factor in the
increased expression of pumps MEXAB-OPRM, started its
presence in samples containing ESBL has been reported in
the world. Several reasons can explain the relationship bet-
ween nalc and beta-lactamase such as the eﬀects of creation
of nalc, is the increase of expression of porin MEX AB-
OPRM. Our results showed that the presence of nalC occur-
redconcomitantwithresistancetooxacilin.Thus,theﬁnding
suggested a relationship between oxacilin resistance and the
presence of nalC and consequently overproduction of the
MexAB-OprM eﬄux system. Our results revealed that more
study is needed for ﬁnding a way which is able to reduce the
oxacilin resistance and lead to reduction of production of
MexAB-OprM eﬄux system.
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